| Pharmaceutical Information |
| Drug Name |
Procyclidine hydrochloride |
| Drug ID |
BADD_D01851 |
| Description |
A muscarinic antagonist that crosses the blood-brain barrier and is used in the treatment of drug-induced extrapyramidal disorders and in parkinsonism. |
| Indications and Usage |
For the treatment of all forms of Parkinson's Disease, as well as control of extrapyramidal reactions induced by antipsychotic agents. |
| Marketing Status |
approved |
| ATC Code |
N04AA04 |
| DrugBank ID |
DB00387
|
| KEGG ID |
D00782
|
| MeSH ID |
D011352
|
| PubChem ID |
207837
|
| TTD Drug ID |
D0R1WR
|
| NDC Product Code |
17337-0090 |
| UNII |
CQC932Z7YW
|
| Synonyms |
Procyclidine | Tricyclamol | Procyclidine Hydrochloride | Hydrochloride, Procyclidine | Kemadren | Mucinil | Procyclid | Kemadrin | Osnervan | Arpicolin |
|
| Chemical Information |
| Molecular Formula |
C19H30ClNO |
| CAS Registry Number |
30953-82-3 |
| SMILES |
C1CCC(CC1)C(CCN2CCCC2)(C3=CC=CC=C3)O.Cl |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
